Literature DB >> 11096706

Focal Brain Lesions in People with HIV.

.   

Abstract

Patients presenting with neurologic symptoms and evidence of focal brain disorders should be evaluated immediately. The clinical presentation of focal brain lesions reflects the function in the area of brain involved. Typical symptoms or signs can include motor or sensory deficits, visual complaints, headache, seizures, or changing level of arousal. Initial studies of key importance include magnetic resonance brain imaging with and without a contrast agent such as gadolinium. When clinically safe, lumbar puncture for detailed cerebrospinal fluid (CSF) analysis is very helpful in the differential diagnosis. Combined clinical, radiologic, and diagnostic evaluation of the CSF can often provide solid evidence of the cause of the lesion(s) and may obviate the need for brain biopsy. The status of systemic human immunodeficiency virus (HIV) infection is important in the differential diagnosis, choice of therapy, and prognosis. Thus, concurrent evaluation of the history and status of the HIV infection is vital. Determination of a specific cause of symptomatic focal lesions is important; this should be pursued aggressively unless the global status of the subject suggests that therapy would be futile. With current therapy, many patients presenting with aggressive focal brain lesions can be successfully treated and can return to productive lives.

Entities:  

Year:  1999        PMID: 11096706     DOI: 10.1007/s11940-999-0016-6

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.972


  17 in total

1.  Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group.

Authors:  B Dannemann; J A McCutchan; D Israelski; D Antoniskis; C Leport; B Luft; J Nussbaum; N Clumeck; P Morlat; J Chiu
Journal:  Ann Intern Med       Date:  1992-01-01       Impact factor: 25.391

2.  Polymerase chain reaction for detection of JC virus DNA in cerebrospinal fluid: a quality control study. European Union Concerted Action on Viral Meningitis and Encephalitis.

Authors:  T Weber; P E Klapper; G M Cleator; M Bodemer; W Lüke; W Knowles; P Cinque; A M Van Loon; M Grandien; A L Hammarin; M Ciardi; G Bogdanovic
Journal:  J Virol Methods       Date:  1997-12       Impact factor: 2.014

Review 3.  Evaluation and management of intracranial mass lesions in AIDS. Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors: 
Journal:  Neurology       Date:  1998-01       Impact factor: 9.910

4.  Multiplex PCR for diagnosis of AIDS-related central nervous system lymphoma and toxoplasmosis.

Authors:  T C Roberts; G A Storch
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

Review 5.  Drug treatment of HIV-related opportunistic infections.

Authors:  M E Klepser; T B Klepser
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

6.  Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group.

Authors:  D Torre; S Casari; F Speranza; A Donisi; G Gregis; A Poggio; S Ranieri; A Orani; G Angarano; F Chiodo; G Fiori; G Carosi
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

7.  Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.

Authors:  P Cinque; M Brytting; L Vago; A Castagna; C Parravicini; N Zanchetta; A D'Arminio Monforte; B Wahren; A Lazzarin; A Linde
Journal:  Lancet       Date:  1993-08-14       Impact factor: 79.321

8.  Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients.

Authors:  M Lorberboym; F Wallach; L Estok; R E Mosesson; M Sacher; C K Kim; J Machac
Journal:  J Nucl Med       Date:  1998-08       Impact factor: 10.057

9.  Limited value of cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis associated with AIDS.

Authors:  C Eggers; U Gross; H Klinker; B Schalke; H J Stellbrink; K Kunze
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

10.  Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study.

Authors:  S S Huang; R L Skolasky; G J Dal Pan; W Royal; J C McArthur
Journal:  J Neurovirol       Date:  1998-06       Impact factor: 2.643

View more
  1 in total

1.  Brain biopsy in AIDS patients: diagnostic yield and treatment applications.

Authors:  Zion Zibly; Itzchak Levy; Vlady Litchevski; Dvora Nass; Chen Hofmann; Jacob Barham; Christian A Graves; Roberto Spiegelmann; Moshe Hadani; Zvi R Cohen
Journal:  AIDS Res Ther       Date:  2014-01-21       Impact factor: 2.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.